![Mark Timney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Timney
Directeur Général chez
Attralus, Inc.
Profil
Actuellement, Mark Timney est président de Blade Therapeutics, Inc. et directeur général et administrateur de The Medicines Co. M. Timney est également membre du conseil d'administration de Biotechnology Innovation Organization, de Pharmaceutical Research & Manufacturers of America et de Sarissa Capital Acquisition Corp. Au cours de sa carrière, M. Timney a occupé les postes de président et de chef de la direction de Purdue Pharma LP, de président mondial des soins primaires chez Merck & Co., Inc. et de chef de la direction et directeur de The Medicines Co. Mark Timney a obtenu un diplôme de premier cycle à l'université de Northumbria.
Postes actifs de Mark Timney
| Sociétés | Poste | Début |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Directeur/Membre du Conseil | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Directeur/Membre du Conseil | - |
Blade Therapeutics, Inc.
 Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Président | 01/08/2020 |
Attralus, Inc.
 Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Directeur Général | 10/05/2021 |
Anfield Road LLC | Directeur Général | 01/01/2017 |
Anciens postes connus de Mark Timney
| Sociétés | Poste | Fin |
|---|---|---|
| SARISSA CAPITAL ACQUISITION CORP. | Directeur/Membre du Conseil | 13/04/2023 |
| THE MEDICINES COMPANY | Directeur Général | 01/01/2020 |
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Directeur Général | 23/06/2017 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/07/2014 |
Formation de Mark Timney
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
90
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of Northumbria
 University of Northumbria Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Blade Therapeutics, Inc.
Blade Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that focuses on developing treatments for fibrotic and neurodegenerative diseases | Health Technology |
Attralus, Inc.
Attralus, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pan-amyloid removal therapeutics | Health Technology |
Sarissa Capital Acquisition Corp.
 Sarissa Capital Acquisition Corp. Financial ConglomeratesFinance Operates as blank check company | Finance |
Anfield Road LLC |
Choisissez Zonebourse 
